KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Receivables - Other for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 6.67% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 6.67% year-over-year, with the annual reading at $1.4 million for FY2025, 6.67% down from the prior year.
  • Receivables - Other for Q4 2025 was $1.4 million at Xenon Pharmaceuticals, up from $812000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $1.5 million in Q4 2024, with the low at $812000.0 in Q3 2025.